Premier Cryogenics Limited Unlisted Share
₹323▲0.00%(0.00)
About the company
Premier Cryogenics Limited is one of the leading manufacturers and suppliers of industrial and medical gases in India's North-East region. Established in 1996, the company has built a strong reputation for delivering high-quality gas products and reliable solutions to industries including healthcare, manufacturing, engineering, infrastructure, pharmaceuticals, and research institutions. With decades of industry experience, Premier Cryogenics has become a trusted partner for businesses requiring consistent and efficient gas supply.
The company's extensive product portfolio includes Liquid Nitrogen, Liquid Oxygen, Industrial Oxygen, Medical Oxygen, Industrial and High-Purity Nitrogen Gas, Dissolved Acetylene, Dry Compressed Air, and a wide range of specialty gases such as Helium, Hydrogen, Freon, Calibration Gases, Gas Mixtures, and Ultra-High Purity Gases. In addition to gas manufacturing and distribution, the company supplies essential gas industry equipment and accessories, including cylinders, cryogenic liquid containers, valves, pressure regulators, and other critical components, enabling customers to source complete gas handling solutions from a single provider.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | — |
| 52 week low | — |
| P/B ratio | 1.83 |
| Debt to equity | 0.27 |
| ROE (%) | 14.03% |
| Book value | ₹176.71 |
| Face value | ₹10 |
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| P/B ratio | 1.83 |
| Debt | 21.3% of capital |
| Equity | 78.7% of capital |
| ROE (%) | 14.03% |
Registry
| Metric | Value |
|---|---|
| PAN number | AABCP6683N |
| ISIN number | INE101F01017 |
Figures in lk ·
Financials
| P&L Statement | 2023Latest | 2022 | 2021 |
|---|---|---|---|
| Revenue | 7748 | 9524 | 5681 |
| EBITDA | 2282 | 2689 | 1520 |
| OPM | 29.45 | 28.23 | 26.76 |
| PBT | 1616 | 2175 | 964 |
| PAT | 1219 | 1637 | 718 |
| EPS | 24.35 | 32.7 | 14.34 |
Shareholding Pattern
Promoters
Derby Commodities Private Limited
Other
| Holder | Percentage |
|---|---|
| Promoters | 38.02% |
| Derby Commodities Private Limited | 29.45% |
| Other | 32.53% |
Frequently asked questions
Common questions on Premier Cryogenics Limited Unlisted Share—tap a row to read the answer.
Q.1What does Premier Cryogenics Limited do?
Premier Cryogenics Limited is an industrial and medical gases manufacturer established in 1996. The company produces products such as Liquid Oxygen, Liquid Nitrogen, Medical Oxygen, Industrial Oxygen, High-Purity Nitrogen, Dissolved Acetylene, and Dry Compressed Air. It also supplies specialty gases, cryogenic equipment, cylinders, valves, pressure regulators, and other components used across industries including healthcare, manufacturing, engineering, pharmaceuticals, and research laboratories.
Q.2Can I buy Premier Cryogenics Limited unlisted shares?
Yes. Investors can purchase Premier Cryogenics Limited unlisted shares through off-market transactions, subject to the availability of shares. Since the company is not listed on a recognized stock exchange, these transactions take place privately between buyers and sellers, with the shares being transferred electronically to the investor's demat account after the necessary documentation is completed.
Q.3Is investing in Premier Cryogenics Limited unlisted shares legal in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction complies with applicable regulations and is completed through the prescribed depository process. Investors should ensure that the shares are transferred through a valid demat account and that all required documentation is properly verified before investing.
Q.4What should investors evaluate before investing in Premier Cryogenics Limited?
Before investing, investors should review the company's financial performance, revenue growth, profitability, manufacturing capacity, customer base, management quality, industry outlook, and future expansion plans. It is also important to understand the company's valuation, competitive position, and the liquidity risks associated with unlisted shares before making an investment decision.
Q.5Why are investors interested in Premier Cryogenics Limited?
Premier Cryogenics Limited operates in the industrial and medical gases sector, which plays a critical role in healthcare, manufacturing, infrastructure, pharmaceuticals, and scientific research. Increasing industrial activity, rising healthcare demand, and infrastructure development continue to support long-term demand for industrial gases, making companies in this sector attractive to long-term investors.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
